
Delayed diagnosis of Brugada syndrome in a patient with aborted sudden cardiac death and initial negative flecainide challenge
Author(s) -
Chauveau Samuel,
Le Vavasseur Olivier,
Chevalier Philippe
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1198
Subject(s) - flecainide , medicine , brugada syndrome , cardiology , sodium channel blocker , sudden cardiac death , sodium channel , atrial fibrillation , sodium , chemistry , organic chemistry
Key Clinical Message A negative flecainide challenge does not rule out Brugada syndrome even in the presence of nonfatal cardiac arrest as the first manifestation of the disease. This should prompt clinicians to ensure long‐term ECG follow‐up and consider repeating a drug test with another sodium channel blocker.